The gut microbiome and intestinal failure-associated liver disease

Berger, 2014, The 2013 Arvid Wretlind lecture: evolving concepts in parenteral nutrition, Clin Nutr, 33, 563, 10.1016/j.clnu.2014.03.005 Lauriti, 2014, Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review, JPEN J Parenter Enter Nutr, 38, 70, 10.1177/0148607113496280 Javid, 2018, J Pediatr Surg, 53, 1399, 10.1016/j.jpedsurg.2017.08.049 Nowak, 2020, Parenteral nutrition-associated liver disease, Clin Liver Dis, 15, 59, 10.1002/cld.888 Mullady, 2006, Treatment of intestinal failure: home parenteral nutrition, Nat Clin Pract Gastroenterol Hepatol, 3, 492, 10.1038/ncpgasthep0580 Zhu, 2013, Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH, Hepatology, 57, 601, 10.1002/hep.26093 Loomba, 2019, Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease, Cell Metab, 30, 607, 10.1016/j.cmet.2019.08.002 Chen, 2011, Characterization of fecal microbial communities in patients with liver cirrhosis, Hepatology, 54, 562, 10.1002/hep.24423 Ponziani, 2019, Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease, Hepatology, 69, 107, 10.1002/hep.30036 Madnawat, 2020, Mechanisms of parenteral nutrition-associated liver and gut injury, Nutr Clin Pract, 35, 63, 10.1002/ncp.10461 Nandivada, 2013, Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions, Adv Nutr, 4, 711, 10.3945/an.113.004770 Deol, 2017, Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice, Sci Rep, 7, 12488, 10.1038/s41598-017-12624-9 Bharadwaj, 2015, Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease, Gastroenterol Rep, 3, 110, 10.1093/gastro/gov011 de Meijer, 2010, Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease, Arch Surg, 145, 547, 10.1001/archsurg.2010.80 Nandivada, 2015, The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy, Ann Surg, 261, 172, 10.1097/SLA.0000000000000445 Clayton, 1993, Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease, Gastroenterology, 105, 1806, 10.1016/0016-5085(93)91079-W El Kasmi, 2013, Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease, Sci Transl Med, 5, 206ra137, 10.1126/scitranslmed.3006898 El Kasmi, 2018, Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis, Nat Commun, 9, 1393, 10.1038/s41467-018-03764-1 McGuckin, 2011, Mucin dynamics and enteric pathogens, Nat Rev Microbiol, 9, 265, 10.1038/nrmicro2538 Mu, 2017, Leaky gut as a danger signal for autoimmune diseases, Front Immunol, 8, 598, 10.3389/fimmu.2017.00598 Chu, 2019, Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease, Gut, 68, 359, 10.1136/gutjnl-2018-316307 Jiang, 2020, Gut microbiota in liver disease: what do we know and what do we not know?, Physiology, 35, 261, 10.1152/physiol.00005.2020 Lee, 2020, Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management, Hepatol Int, 14, 305, 10.1007/s12072-020-10048-8 Ralls, 2015, Enteral nutrient deprivation in patients leads to a loss of intestinal epithelial barrier function, Surgery, 157, 732, 10.1016/j.surg.2014.12.004 Feng, 2009, Dissociation of E-cadherin and beta-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophy, J Physiol, 587, 641, 10.1113/jphysiol.2008.162719 Liu, 2021, Lin 28A/Occludin axis: an aberrantly activated pathway in intestinal epithelial cells leading to impaired barrier function under total parenteral nutrition, FASEB J, 35, e21189 Alverdy, 1988, Total parenteral nutrition promotes bacterial translocation from the gut, Surgery, 104, 185 Heneghan, 2014, IL-25 improves luminal innate immunity and barrier function during parenteral nutrition, Ann Surg, 259, 394, 10.1097/SLA.0b013e318284f510 Fukatsu, 2001, TPN decreases IL-4 and IL-10 mRNA expression in lipopolysaccharide stimulated intestinal lamina propria cells but glutamine supplementation preserves the expression, Shock, 15, 318, 10.1097/00024382-200115040-00012 Renegar, 2001, Impairment of mucosal immunity by total parenteral nutrition: requirement for IgA in murine nasotracheal anti-influenza immunity, J Immunol, 166, 819, 10.4049/jimmunol.166.2.819 Hermsen, 2009, Food fight! Parenteral nutrition, enteral stimulation and gut-derived mucosal immunity, Langenbecks Arch Surg, 394, 17, 10.1007/s00423-008-0339-x Lan, 2011, Parenteral nutrition impairs lymphotoxin β receptor signaling via NF-κB, Ann Surg, 253, 996, 10.1097/SLA.0b013e31821224eb Willis, 2020, TGR5 signaling mitigates parenteral nutrition-associated liver disease, Am J Physiol Gastrointest Liver Physiol, 318, G322, 10.1152/ajpgi.00216.2019 Demehri, 2013, Intestinal epithelial cell apoptosis and loss of barrier function in the setting of altered microbiota with enteral nutrient deprivation, Front Cell Infect Microbiol, 3, 105, 10.3389/fcimb.2013.00105 Rodríguez, 2015, The composition of the gut microbiota throughout life, with an emphasis on early life, Microb Ecol Health Dis, 26, 26050 Gérard, 2013, Metabolism of cholesterol and bile acids by the gut microbiota, Pathogens, 3, 14, 10.3390/pathogens3010014 Makki, 2018, The impact of dietary fiber on gut microbiota in host health and disease, Cell Host Microbe, 23, 705, 10.1016/j.chom.2018.05.012 Yatsunenko, 2012, Human gut microbiome viewed across age and geography, Nature, 486, 222, 10.1038/nature11053 Dethlefsen, 2011, Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation, Proc Natl Acad Sci U S A, 108, 4554, 10.1073/pnas.1000087107 Dupont, 2020, The intestinal microbiome in human health and disease, Trans Am Clin Climatol Assoc, 131, 178 Ralls, 2014, Intestinal microbial diversity and perioperative complications, JPEN J Parenter Enter Nutr, 38, 392, 10.1177/0148607113486482 Jiang, 2022, Role of the gut microbiota in parenteral nutrition-associated liver disease: from current knowledge to future opportunities, J Nutr, 152, 377, 10.1093/jn/nxab380 Harvey, 2006, Qualitative and quantitative comparison of gut bacterial colonization in enterally and parenterally fed neonatal pigs, Curr Issues Intest Microbiol, 7, 61 Lavallee, 2017, Lipid emulsion formulation of parenteral nutrition affects intestinal microbiota and host responses in neonatal piglets, JPEN J Parenter Enter Nutr, 41, 1301, 10.1177/0148607116662972 Call, 2020, Parenteral lipids shape gut bile acid pools and microbiota profiles in the prevention of cholestasis in preterm pigs, J Lipid Res, 61, 1038, 10.1194/jlr.RA120000652 Siggers, 2011, Nutritional modulation of the gut microbiota and immune system in preterm neonates susceptible to necrotizing enterocolitis, J Nutr Biochem, 22, 511, 10.1016/j.jnutbio.2010.08.002 Dahlgren, 2019, Longitudinal changes in the gut microbiome of infants on total parenteral nutrition, Pediatr Res, 86, 107, 10.1038/s41390-019-0391-y Günşar, 2010, Antibiotic treatment is superior to ursodeoxycholic acid on total parenteral nutrition associated hepatic dysfunction, Pediatr Surg Int, 26, 479, 10.1007/s00383-010-2578-5 Jia, 2020, Impact of postnatal antibiotics and parenteral nutrition on the gut microbiota in preterm infants during early life, JPEN J Parenter Enter Nutr, 44, 639, 10.1002/jpen.1695 Pironi, 2016, ESPEN guidelines on chronic intestinal failure in adults, Clin Nutr, 35, 247, 10.1016/j.clnu.2016.01.020 Devine, 2013, Impact of ileocecal resection and concomitant antibiotics on the microbiome of the murine jejunum and colon, PLoS One, 8, e73140, 10.1371/journal.pone.0073140 Klek, 2016, Management of acute intestinal failure: a position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group, Clin Nutr, 35, 1209, 10.1016/j.clnu.2016.04.009 Davidovics, 2016, The fecal microbiome in pediatric patients with short bowel syndrome, JPEN J Parenter Enter Nutr, 40, 1106, 10.1177/0148607115591216 Korpela, 2017, Intestinal microbiota signatures associated with histological liver steatosis in pediatric-onset intestinal failure, JPEN J Parenter Enter Nutr, 41, 238, 10.1177/0148607115584388 Engstrand Lilja, 2015, Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome, Microbiome, 3, 18, 10.1186/s40168-015-0084-7 Huang, 2017, Fecal microbiota signatures of adult patients with different types of short bowel syndrome, J Gastroenterol Hepatol, 32, 1949, 10.1111/jgh.13806 Budinska, 2020, Microbiome and metabolome profiles associated with different types of short bowel syndrome: implications for treatment, JPEN J Parenter Enter Nutr, 44, 105, 10.1002/jpen.1595 Thomas, 2008, Targeting bile-acid signalling for metabolic diseases, Nat Rev Drug Discov, 7, 678, 10.1038/nrd2619 Trauner, 2003, Bile salt transporters: molecular characterization, function, and regulation, Physiol Rev, 83, 633, 10.1152/physrev.00027.2002 Meier, 2002, Bile salt transporters, Annu Rev Physiol, 64, 635, 10.1146/annurev.physiol.64.082201.100300 Dawson, 2009, Bile acid transporters, J Lipid Res, 50, 2340, 10.1194/jlr.R900012-JLR200 Geyer, 2006, The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships, Naunyn Schmiedebergs Arch Pharmacol, 372, 413, 10.1007/s00210-006-0043-8 Di Ciaula, 2017, Bile acid physiology, Ann Hepatol, 16, s4, 10.5604/01.3001.0010.5493 Ridlon, 2014, Bile acids and the gut microbiome, Curr Opin Gastroenterol, 30, 332, 10.1097/MOG.0000000000000057 Pakarinen, 2010, Cholesterol metabolism in pediatric short bowel syndrome after weaning off parenteral nutrition, Dig Liver Dis, 42, 554, 10.1016/j.dld.2010.01.003 Ellegård, 2005, High serum phytosterol levels in short bowel patients on parenteral nutrition support, Clin Nutr, 24, 415, 10.1016/j.clnu.2005.01.001 Mutanen, 2015, Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure, J Hepatol, 62, 1391, 10.1016/j.jhep.2015.01.004 Keitel, 2012, Perspective: TGR5 (Gpbar-1) in liver physiology and disease, Clin Res Hepatol Gastroenterol, 36, 412, 10.1016/j.clinre.2012.03.008 Macfarlane, 2012, Bacteria, colonic fermentation, and gastrointestinal health, J AOAC Int, 95, 50, 10.5740/jaoacint.SGE_Macfarlane Wong, 2006, Colonic health: fermentation and short chain fatty acids, J Clin Gastroenterol, 40, 235, 10.1097/00004836-200603000-00015 Frankel, 1994, Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon, Gastroenterology, 106, 375, 10.1016/0016-5085(94)90595-9 den Besten, 2013, Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids, Am J Physiol Gastrointest Liver Physiol, 305, G900, 10.1152/ajpgi.00265.2013 Dowhaniuk, 2020, Starving the gut: a deficit of butyrate in the intestinal ecosystem of children with intestinal failure, JPEN J Parenter Enter Nutr, 44, 1112, 10.1002/jpen.1715 Jirsova, 2019, The effect of butyrate-supplemented parenteral nutrition on intestinal defence mechanisms and the parenteral nutrition-induced shift in the gut microbiota in the rat model, Biomed Res Int, 2019, 10.1155/2019/7084734 Bartholome, 2004, Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets, JPEN J Parenter Enter Nutr, 28, 210, 10.1177/0148607104028004210 Yan, 2017, Sodium butyrate attenuates soybean oil-based lipid emulsion-induced increase in intestinal permeability of lipopolysaccharide by modulation of P-glycoprotein in Caco-2 cells, Biochem Biophys Res Commun, 482, 791, 10.1016/j.bbrc.2016.11.112 Sanchez, 2013, The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants, J Pediatr Surg, 48, 573, 10.1016/j.jpedsurg.2012.08.016 Calkins, 2017, Low-dose parenteral soybean oil for the prevention of parenteral nutrition-associated liver disease in neonates with gastrointestinal disorders, JPEN J Parenter Enter Nutr, 41, 404, 10.1177/0148607115588334 Bluemel, 2016, Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota, Am J Physiol Gastrointest Liver Physiol, 311, G1018, 10.1152/ajpgi.00245.2016 Sanders, 2019, Probiotics and prebiotics in intestinal health and disease: from biology to the clinic, Nat Rev Gastroenterol Hepatol, 16, 605, 10.1038/s41575-019-0173-3 Sentongo, 2008, Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome, J Pediatr Gastroenterol Nutr, 46, 41, 10.1097/01.mpg.0000304452.92175.f5 Uchida, 2007, Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome, Pediatr Surg Int, 23, 243, 10.1007/s00383-006-1866-6 Sieczkowska, 2016, Small bowel bacterial overgrowth in children, J Pediatr Gastroenterol Nutr, 62, 196, 10.1097/MPG.0000000000000920 Spurr, 1989, Hyperalimentation-associated neonatal cholestasis: effect of oral gentamicin, JPEN J Parenter Enter Nutr, 13, 633, 10.1177/0148607189013006633 Kubota, 1990, The effect of metronidazole on TPN-associated liver dysfunction in neonates, J Pediatr Surg, 25, 618, 10.1016/0022-3468(90)90347-C